» Articles » PMID: 33468668

Positive Epistasis Between Disease-causing Missense Mutations and Silent Polymorphism with Effect on MRNA Translation Velocity

Overview
Specialty Science
Date 2021 Jan 20
PMID 33468668
Citations 17
Authors
Affiliations
Soon will be listed here.
Abstract

Epistasis refers to the dependence of a mutation on other mutation(s) and the genetic context in general. In the context of human disorders, epistasis complicates the spectrum of disease symptoms and has been proposed as a major contributor to variations in disease outcome. The nonadditive relationship between mutations and the lack of complete understanding of the underlying physiological effects limit our ability to predict phenotypic outcome. Here, we report positive epistasis between intragenic mutations in the cystic fibrosis transmembrane conductance regulator (CFTR)-the gene responsible for cystic fibrosis (CF) pathology. We identified a synonymous single-nucleotide polymorphism (sSNP) that is invariant for the CFTR amino acid sequence but inverts translation speed at the affected codon. This sSNP in exhibits positive epistatic effects on some CF disease-causing missense mutations. Individually, both mutations alter CFTR structure and function, yet when combined, they lead to enhanced protein expression and activity. The most robust effect was observed when the sSNP was present in combination with missense mutations that, along with the primary amino acid change, also alter the speed of translation at the affected codon. Functional studies revealed that synergistic alteration in ribosomal velocity is the underlying mechanism; alteration of translation speed likely increases the time window for establishing crucial domain-domain interactions that are otherwise perturbed by each individual mutation.

Citing Articles

Rescue of Mutant CFTR Channel Activity by Investigational Co-Potentiator Therapy.

Bacalhau M, Ferreira F, Azevedo M, Rosa T, Buarque C, Lopes-Pacheco M Biomedicines. 2025; 13(1).

PMID: 39857666 PMC: 11762957. DOI: 10.3390/biomedicines13010082.


Distinct network patterns emerge from Cartesian and XOR epistasis models: a comparative network science analysis.

Sha Z, Freda P, Bhandary P, Ghosh A, Matsumoto N, Moore J BioData Min. 2024; 17(1):61.

PMID: 39732697 PMC: 11681696. DOI: 10.1186/s13040-024-00413-w.


A fundamental and theoretical framework for mutation interactions and epistasis.

Giacoletto C, Benjamin R, Rotter J, Schiller M Genomics. 2024; 116(6):110963.

PMID: 39561884 PMC: 11752442. DOI: 10.1016/j.ygeno.2024.110963.


Ribosomal frameshifting selectively modulates the assembly, function, and pharmacological rescue of a misfolded CFTR variant.

Carmody P, Roushar F, Tedman A, Wang W, Herwig M, Kim M Proc Natl Acad Sci U S A. 2024; 121(42):e2414768121.

PMID: 39388263 PMC: 11494300. DOI: 10.1073/pnas.2414768121.


Ribosomal Frameshifting Selectively Modulates the Assembly, Function, and Pharmacological Rescue of a Misfolded CFTR Variant.

Carmody P, Roushar F, Tedman A, Wang W, Herwig M, Kim M bioRxiv. 2024; .

PMID: 39091758 PMC: 11290997. DOI: 10.1101/2023.05.02.539166.


References
1.
Bank C, Hietpas R, Jensen J, Bolon D . A systematic survey of an intragenic epistatic landscape. Mol Biol Evol. 2014; 32(1):229-38. PMC: 4271534. DOI: 10.1093/molbev/msu301. View

2.
Wang X, Fu A, McNerney M, White K . Widespread genetic epistasis among cancer genes. Nat Commun. 2014; 5:4828. DOI: 10.1038/ncomms5828. View

3.
Kimchi-Sarfaty C, Oh J, Kim I, Sauna Z, Calcagno A, Ambudkar S . A "silent" polymorphism in the MDR1 gene changes substrate specificity. Science. 2006; 315(5811):525-8. DOI: 10.1126/science.1135308. View

4.
Canale A, Venev S, Whitfield T, Caffrey D, Marasco W, Schiffer C . Synonymous Mutations at the Beginning of the Influenza A Virus Hemagglutinin Gene Impact Experimental Fitness. J Mol Biol. 2018; 430(8):1098-1115. DOI: 10.1016/j.jmb.2018.02.009. View

5.
Supek F, Minana B, Valcarcel J, Gabaldon T, Lehner B . Synonymous mutations frequently act as driver mutations in human cancers. Cell. 2014; 156(6):1324-1335. DOI: 10.1016/j.cell.2014.01.051. View